The FDA introduced an AI tool named ELSA to assist with scientific reviews, but employees report the system frequently "hallucinates" fake studies. FDA Commissioner Dr. Marty McCary noted that while the tool helps with organization, it cannot yet be trusted for critical data analysis in drug approvals. The reliance on AI has reportedly increased the workload for human reviewers who must double-check all machine-generated summaries.
